December 09, 2024
A University of Oklahoma Health Sciences clinical trial studying whether a drug called blinatumomab, when given in conjunction with chemotherapy, would improve patients’ survival without the cancer returning will now be standard practice to give in combination with chemotherapy to children with standard-risk B-ALL, the most common childhood cancer.
November 26, 2024
OU College of Medicine is one of 39 trial sites nationwide that found embolization plus surgery reduces risk of brain bleed recurrence.